1 - 1 / 1 1 |
1. Novel mTOR inhibitors with distinct anticancer profiles and favorable DMPK properties Rose M. Sheridan, Matthew Alan Gregory, Hrvoje Petković, Sabine Gaisser, Rachel E. Lill, Steven J. Moss, Susan Cheng, Chris Proud, Miguel Quimpère, Barrie Wilkinson, Ming-Qiang Zhang, 2005, objavljeni povzetek znanstvenega prispevka na konferenci Ključne besede: rapamicin, mTOR, protirakaste učinkovine |